Project StrepTag3D
For modern therapies, cells and proteins must be efficiently purified and selected from complex solutions such as blood. In practice, bead-based chromatography columns using agarose are frequently used for this purpose. However, these are relatively expensive, pressure-sensitive, and limit potential throughput due to their material properties. For future biotechnological and medical applications, therefore, more cost-effective, robust, and at the same time high-performance alternatives are needed.
This is where the “StrepTag3D” project comes in. The goal is to use 3D printing to create cost-effective alternatives. A key challenge is that polymer surfaces are initially inert with respect to specific functionalization. To address this, Fraunhofer IST has developed a plasma source that can be integrated directly into the extrusion process of an FDM printer. In this way, reactive binding sites can be created on the polymer surface during the printing process using a solvent-free method, to which selective capture molecules can be coupled.
When combined with the 3D-printed structures developed by BellaSeno and the purification protocols developed by IBA Lifesciences, this technology opens up new possibilities for purification, for example in biotechnological processes. In the future, these additively manufactured and functionalized structures will also enable systems for purification in therapeutic applications that are more cost-effective and sustainable to produce.